Long non-coding RNA LINC00987 may function as a tumor suppressor in lung adenocarcinoma

Adrian Salavaty; Zahra Rezvani; Ali Najafi

doi:10.12688/f1000research.14785.1

Home Browse Long non-coding RNA LINC00987 may function as a tumor suppressor in...

ALL Metrics

Views

Downloads

Get PDF

Get XML

Export

▬

✚

Brief Report

Long non-coding RNA LINC00987 may function as a tumor suppressor in lung adenocarcinoma

[version 1; peer review: 1 approved with reservations, 1 not approved]

Adrian Salavaty¹, Zahra Rezvani¹, Ali Najafi²

PUBLISHED 04 May 2018

Author details Author details

¹ Division of Biotechnology, Department of Cell and Molecular Biology, Faculty of Chemistry, University of Kashan, Kashan, Iran
² Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

Adrian Salavaty
Roles: Conceptualization, Data Curation, Visualization, Writing – Original Draft Preparation

Zahra Rezvani
Roles: Conceptualization, Supervision, Writing – Review & Editing

Ali Najafi
Roles: Conceptualization, Supervision, Writing – Review & Editing

OPEN PEER REVIEW

REVIEWER STATUS

Abstract

Long non-coding RNAs (lncRNAs) are a group of transcripts over 200 nucleotides in length that do not code for proteins. The association of the dysregulation of numerous lncRNAs with several malignancies, including lung cancer, has been frequently reported. This study aims to inspect the association of genomic and transcriptomic alterations to the lncRNA LINC00987 with lung adenocarcinoma, a subtype of lung cancer, using a bioinformatic approach. To this end, we used three publically available online databases, cBioPortal, the International Cancer Genome Consortium Data Portal and the GEPIA web server. In short, our results demonstrated that LINC00987 expression might have a tumor suppressive role in lung adenocarcinoma and levels of expression could be of prognostic value for this cancer type.

Keywords

LINC00987, Lung adenocarcinoma, Tumor suppressor lncRNA, Genotranscriptomic analysis, Bioinformatics

Corresponding authors: Zahra Rezvani, Ali Najafi

Competing interests: No competing interests were disclosed.

Grant information: The author(s) declared that no grants were involved in supporting this work.

Copyright: © 2018 Salavaty A et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

How to cite: Salavaty A, Rezvani Z and Najafi A. Long non-coding RNA LINC00987 may function as a tumor suppressor in lung adenocarcinoma [version 1; peer review: 1 approved with reservations, 1 not approved]. F1000Research 2018, 7:540 (https://doi.org/10.12688/f1000research.14785.1) First published: 04 May 2018, 7:540 (https://doi.org/10.12688/f1000research.14785.1) Latest published: 04 May 2018, 7:540 (https://doi.org/10.12688/f1000research.14785.1)

Introduction

Lung cancer is the leading cause of cancer-related death in the world among both men and women¹. Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer and accounts for over a million cancer-related deaths each year^2,3. Thus, the identification of molecules involved in the initiation and development of LUAD should be a high priority and could help the early diagnosis, prognosis, and treatment of this lethal cancer.

Long non-coding RNAs (lncRNAs) are a subclass of non-protein-coding transcripts over 200 nucleotides in length that are involved in several cancer-related biological processes, including cell growth, cell proliferation, and apoptosis^4,5. It has been frequently reported that lncRNAs, due to their pivotal regulatory roles in the cellular events, especially cell cycle processes, can be used as cancer biomarkers⁶. HOTAIR, for example, is an oncogenic lncRNA that is being used as a biomarker for several cancers⁷. LINC00987 is a poorly known lncRNA that has been observed to be dysregulated in LUAD by microarray studies⁸. However, the genomic and transcriptomic alterations to LINC00987 lncRNA in LUAD have not yet been precisely examined.

In this study, we investigated the association of LINC00987 genomic and transcriptomic alterations with LUAD. Moreover, the relationship between the LINC00987 expression level and the overall survival (OS) of LUAD patients was inspected. To accomplish these goals, three well-known online databases, cBioPortal, the International Cancer Genome Consortium (ICGC) Data Portal and the GEPIA web server, were employed.

Methods

Genomic analysis

Copy number alterations in LINC00987 lncRNA across The Cancer Genome Atlas (TCGA) LUAD study (586 samples) were retrieved from the cBioPortal database^9,10. To this end, the “Putative copy-number alterations from GISTIC” and “All Tumors (586)” were selected as the genomic profile and the patient/case set, respectively. The Gene-level Analysis tool of the TCGA Copy Number Portal (Analysis Version: 2015-06-01 stddata__2015_04_02 regular peel-off)¹¹ was used to determine whether LINC00987 is located within or near any peak region of somatic copy-number alterations in LUAD (516 samples). TCGA Copy Number Portal facilitates the understanding of high resolution copy number data amassed from cancer samples in the TCGA. Furthermore, the mutations to LINC00987 lncRNA in LUAD was analyzed by means of the ICGC Data Portal (https://dcc.icgc.org) To this purpose, the “LINC00987” term was searched in the ICGC Data Portal and the projects related to the LUAD were selected from the results.

Transcriptomic analysis

The GEPIA web server¹² was used to investigate the differential expression of LINC00987 lncRNA between LUAD tumor (#483) and normal (#347) samples. To this end, the Differential Expression Analysis and the Expression DIY Boxplot tools were employed with default options. The association of the differential expression of the LINC00987 lncRNA with the OS of LUAD patients was examined using the Survival Plots tool of the GEPIA web server with default parameters.

Results

LINC00987 has genomic alterations in LUAD

Copy number alteration analysis of LINC00987 demonstrated that this lncRNA was deeply deleted in over 4 percent of LUAD sequenced cases/patients (Figure 1a). However, LINC00987 lncRNA was amplified in 5 out of 230 LUAD sequenced samples. Analysis of somatic copy-number alterations to LINC00987 demonstrated that this lncRNA is located within a focal peak region of deletion (chr12:2782810-17821101) in LUAD (overall frequency of deletion: 0.2578; q-value: 0.0802). In addition, our results indicated that LINC00987 was mutated in 6.06% of LUAD donors, including chr12:g.9392556T>C, chr12:g.9392654T>C, and chr12:g.9393053C>G, according to the LUNG CANCER - KR project.

Figure 1. Genomic and transcriptomic alterations of LINC00987 long non-coding RNA (lncRNA) in lung adenocarcinoma (LUAD).

(a) Copy number alterations of LINC00987 in LUAD according to the The Cancer Genome Atlas data (230 sequenced samples). Red, blue, and gray colors are indicative of amplified (n=10), deleted (n=5), and non-altered (n=215) samples, respectively. Cumulatively, 7% (n=15) of the sequenced samples had copy number alterations. The figure was retrieved from the cBioPortal database. (b) Dysregulation of LINC00987 lncRNA in LUAD. The asterisk indicates the extreme outliers. The figure was created using Boxplot function in Expression DIY of the GEPIA web server. (c) The association of LINC00987 expression level with the overall survival of LUAD patients. The figure was created using the GEPIA web server.

LINC00987 is downregulated in LUAD

Transcriptomic analysis of LINC00987 using the GEPIA web server showed that this lncRNA was significantly downregulated (log₂(fold change) = −1.225; adjusted p-value = 1.17e⁻¹²⁹) in LUAD (Figure 1b). Survival analysis indicated that the expression level of LINC00987 is significantly related (log-rank p-value = 0.0023) to the OS of LUAD patients (Figure 1c).

Dataset 1.The copy number alteration raw data, retrieved from the cBioPortal database.

Discussion

The aim of this study was to examine the association of genotranscriptomic alterations of LINC00987 lncRNA with LUAD using a bioinformatic approach. There is an increasing number of publications revealing the key roles of lncRNAs in cancer development and their potential as cancer biomarker.

According to our results, LINC00987 lncRNA is deleted in a significant proportion of the LUAD cases. LINC00987 was mutated in over 6 percent of LUAD patients. Frequent deletion and functional mutations are characteristic of dysregulated tumor suppressor genes in cancer^13–15. LINC00987 lncRNA is under-expressed in LUAD samples compared with normal samples. Furthermore, survival analysis indicated that downregulation of LINC00987 lncRNA is associated with a lower OS period in LUAD patients. These cues, (that is, the under-expression of LINC00987 in cancer and the positive association of its expression level with OS of cancer patients) are characteristic of tumor suppressor genes in cancer.

Overall, LINC00987 may be a tumor suppressive lncRNA in LUAD and could be considered as a biomarker for the diagnosis and/or prognosis of patients with this cancer type. However, further bioinformatic and experimental studies are required to decipher the precise function of LINC00987 in lung tissue and evaluate its application as a biomarker for LUAD.

Data availability

Dataset 1. The copy number alteration raw data, retrieved from the cBioPortal database. DOI: 10.5256/f1000research.14785.d202563¹⁶.

All of the results presented in this study can be directly achieved using the procedures described in the Methods section.

Competing interests

No competing interests were disclosed.

Grant information

The author(s) declared that no grants were involved in supporting this work.

Acknowledgements

The results shown in this study are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.

Faculty Opinions recommended

References

1. Torre LA, Siegel RL, Jemal A: Lung Cancer Statistics. Adv Exp Med Biol. 2016; 893: 1–19. PubMed Abstract | Publisher Full Text
2. Chen Z, Fillmore CM, Hammerman PS, et al.: Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014; 14(8): 535–46. PubMed Abstract | Publisher Full Text | Free Full Text
3. Torre LA, Bray F, Siegel RL, et al.: Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2): 87–108. PubMed Abstract | Publisher Full Text
4. Shen XH, Qi P, Du X: Long non-coding RNAs in cancer invasion and metastasis. Mod Pathol. 2015; 28(1): 4–13. PubMed Abstract | Publisher Full Text
5. Anastasiadou E, Jacob LS, Slack FJ: Non-coding RNA networks in cancer. Nat Rev Cancer. 2018; 18(1): 5–18. PubMed Abstract | Publisher Full Text
6. Bolha L, Ravnik-Glavač M, Glavač D: Long Noncoding RNAs as Biomarkers in Cancer. Dis Markers. 2017; 2017: 7243968. PubMed Abstract | Publisher Full Text | Free Full Text
7. Hajjari M, Salavaty A: HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol Med. 2015; 12(1): 1–9. PubMed Abstract | Publisher Full Text | Free Full Text
8. Xu G, Chen J, Pan Q, et al.: Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis. PLoS One. 2014; 9(8): e104044. PubMed Abstract | Publisher Full Text | Free Full Text
9. Gao J, Aksoy BA, Dogrusoz U, et al.: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6(269): pl1. PubMed Abstract | Publisher Full Text | Free Full Text
10. Cerami E, Gao J, Dogrusoz U, et al.: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5): 401–4. PubMed Abstract | Publisher Full Text | Free Full Text
11. Beroukhim R, Mermel CH, Porter D, et al.: The landscape of somatic copy-number alteration across human cancers. Nature. 2010; 463(7283): 899–905. PubMed Abstract | Publisher Full Text | Free Full Text
12. Tang Z, Li C, Kang B, et al.: GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1): W98–W102. PubMed Abstract | Publisher Full Text | Free Full Text
13. Balmain A, Gray J, Ponder B: The genetics and genomics of cancer. Nat Genet. 2003; 33 Suppl: 238–44. PubMed Abstract | Publisher Full Text
14. Dong JT: Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev. 2001; 20(3–4): 173–93. PubMed Abstract | Publisher Full Text
15. Chen J, Fu L, Zhang LY, et al.: Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma. Chin J Cancer. 2012; 31(5): 215–22. PubMed Abstract | Publisher Full Text | Free Full Text
16. Salavaty A, Rezvani Z, Najafi A: Dataset 1 in: Long non-coding RNA LINC00987 may function as a tumor suppressor in lung adenocarcinoma. F1000Research. 2018. Data Source

Comments on this article Comments (0)

Version 1

VERSION 1 PUBLISHED 04 May 2018

Author details Author details

Adrian Salavaty
Roles: Conceptualization, Data Curation, Visualization, Writing – Original Draft Preparation

Zahra Rezvani
Roles: Conceptualization, Supervision, Writing – Review & Editing

Ali Najafi
Roles: Conceptualization, Supervision, Writing – Review & Editing

Competing interests

No competing interests were disclosed.

Grant information

The author(s) declared that no grants were involved in supporting this work.

Article Versions (1)

version 1

Published: 04 May 2018, 7:540

https://doi.org/10.12688/f1000research.14785.1

© 2018 Salavaty A et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

Download

Export To

metrics

	Views	Downloads
F1000Research	-	-
PubMed Central Data from PMC are received and updated monthly.	-	-

Citations

SEE MORE DETAILS

CITE

how to cite this article

Salavaty A, Rezvani Z and Najafi A. Long non-coding RNA LINC00987 may function as a tumor suppressor in lung adenocarcinoma [version 1; peer review: 1 approved with reservations, 1 not approved]. F1000Research 2018, 7:540 (https://doi.org/10.12688/f1000research.14785.1)

NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.

track

receive updates on this article

Track an article to receive email alerts on any updates to this article.

Open Peer Review

Version 1

VERSION 1

PUBLISHED 04 May 2018

Views

Reviewer Report 31 Aug 2018

Wen Cai Zhang, Department of Pathology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA

Approved with Reservations

https://doi.org/10.5256/f1000research.16089.r36973

The authors found that LINC00987 is a new long non-coding RNA which is poorly known in lung adenocarcinoma. Using genomic and transcriptomic databases, the authors discovered that LINC00987 is a tumor suppressive non-coding RNA and its expression levels correlate with patients’ survival. This finding is a good clue to discovering potential roles of LINC00987 in clinical diagnosis and prognosis in lung cancer patients. However, additional data are needed to claim that LINC00987 is a tumor suppressor.

My comments are as below.

Could any known lung relevant lncRNAs (such as MALAT1) be applied and validated using the database (GEPIA)?
Could the author reproduce the data shown in Fig 1b and 1c using a different database to demonstrate differential expressions of LINC00987 in lung adenocarcinoma and normal tissues and survival curve?
Could the author validate the differential expression levels for LINC00987 in several lung adenocarcinoma and normal lung epithelial cell lines?
Furthermore, could plasmids for LINC00987 be applied to validate the tumor suppressive roles in lung adenocarcinoma cell lines?

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Tumor initiation/progression, cancer metabolism, non-coding RNAs

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

CITE

Report a concern

Respond or Comment

Views

Reviewer Report 07 Jun 2018

Antonio Marco, School of Biological Sciences, University of Essex, Colchester, UK

Not Approved

https://doi.org/10.5256/f1000research.16089.r34549

The authors explored major databases of genomic alterations in cancer samples and evaluated a potential role of LINC00987 in Lung Adenocarcinoma.

They concluded that their results "demonstrate that LINC00987 expression might have a tumor suppressive role in lung adenocarcinoma".

As an investigation evaluating the relationship between a non-coding gene an a human disease it is an interesting piece of work. However, I believe that the results are not supported and the work lacks a more appropriate statistical framework.

The choice of LINC00987 as a potential gene involved in this cancer is based on a paper by Xu et al. After screening the paper and the supplementary annotation I haven't found any mention to it. It may be due to a change in nomenclature, but then it must be clearly stated.
The deletion of LINC00987 is associated to a deletion of half on an arm of chromosome 12. There are hundreds of genes in the region so any association to LINC00987 must be clearly differentiated.
Likewise, the expression levels can be associated to this deletion. Hundreds of other genes will be also underexpressed. This also affects the analysis of Figure 1C.

From my point of view, and considering the evidence shown, there is no evidence of a causal connection between LINC00987 and Lung Adenocarcinoma. A convincing analysis should take into account the expected mutation/deletion/expression/survival profile of other genes (expectations) including those in the frequently deleted arm of chromosome 12.

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Non-coding RNAs, Gene expression, Evolution, Genomics, Computational Biology

I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.

CITE

Report a concern

Author Response 08 Jun 2018

Abbas Salavaty, Division of Biotechnology, Department of Cell and Molecular Biology, Faculty of Chemistry, University of Kashan, Kashan, Iran

08 Jun 2018

Author Response
1. We agree with you about the clarification of gene nomenclature. Actually, LINC00987 was previously known as LOC100499405. Please take a look at row 817 of the Table S5
... Continue reading
We agree with you about the clarification of gene nomenclature. Actually, LINC00987 was previously known as LOC100499405. Please take a look at row 817 of the Table S5 of the paper by Xu et al. You may also get this point by checking the RefSeq transcript ID (NR_036466) of LINC00987 and LOC100499405. We will consider clarifying on this point in the next revision of the paper.

According to the results obtained from the TCGA Copy Number Portal, LINC00987 is located within a focal peak region of deletion (chr12:2782810-17821101) in LUAD. Basically, this means that the gene LINC00987 and several other genes are frequently deleted in LUAD patients. However, no distinctive association between LINC00987 deletion and LUAD could be perceived from the results.

It is completely true that deletion of a chromosomal region in a proportion of cells is equal to the underexpression of deleted genes. However, in this study, we specifically focused on the lncRNA LINC00987, not other genes neighboring that. Even though under-expression of other genes might affect the overall survival of LUAD patients, we specifically investigated whether the expression level of LINC00987 is associated with the overall survival of LUAD patients or not. This is a common and approved strategy and statistical analysis.

Actually, this is a research note, not a comprehensive research paper, which could be an inspiring viewpoint for the conduction of further in-silico and in-vitro assays on the association of LINC00987 and LUAD.

Overall, thank you for your precious time and consideration.
We agree with you about the clarification of gene nomenclature. Actually, LINC00987 was previously known as LOC100499405. Please take a look at row 817 of the Table S5 of the paper by Xu et al. You may also get this point by checking the RefSeq transcript ID (NR_036466) of LINC00987 and LOC100499405. We will consider clarifying on this point in the next revision of the paper.

According to the results obtained from the TCGA Copy Number Portal, LINC00987 is located within a focal peak region of deletion (chr12:2782810-17821101) in LUAD. Basically, this means that the gene LINC00987 and several other genes are frequently deleted in LUAD patients. However, no distinctive association between LINC00987 deletion and LUAD could be perceived from the results.

It is completely true that deletion of a chromosomal region in a proportion of cells is equal to the underexpression of deleted genes. However, in this study, we specifically focused on the lncRNA LINC00987, not other genes neighboring that. Even though under-expression of other genes might affect the overall survival of LUAD patients, we specifically investigated whether the expression level of LINC00987 is associated with the overall survival of LUAD patients or not. This is a common and approved strategy and statistical analysis.

Actually, this is a research note, not a comprehensive research paper, which could be an inspiring viewpoint for the conduction of further in-silico and in-vitro assays on the association of LINC00987 and LUAD.

Overall, thank you for your precious time and consideration.
Competing Interests: No competing interests were disclosed. Close
Report a concern
Respond or Comment

COMMENTS ON THIS REPORT

Author Response 08 Jun 2018

Abbas Salavaty, Division of Biotechnology, Department of Cell and Molecular Biology, Faculty of Chemistry, University of Kashan, Kashan, Iran

08 Jun 2018

Author Response
1. We agree with you about the clarification of gene nomenclature. Actually, LINC00987 was previously known as LOC100499405. Please take a look at row 817 of the Table S5
... Continue reading
We agree with you about the clarification of gene nomenclature. Actually, LINC00987 was previously known as LOC100499405. Please take a look at row 817 of the Table S5 of the paper by Xu et al. You may also get this point by checking the RefSeq transcript ID (NR_036466) of LINC00987 and LOC100499405. We will consider clarifying on this point in the next revision of the paper.

According to the results obtained from the TCGA Copy Number Portal, LINC00987 is located within a focal peak region of deletion (chr12:2782810-17821101) in LUAD. Basically, this means that the gene LINC00987 and several other genes are frequently deleted in LUAD patients. However, no distinctive association between LINC00987 deletion and LUAD could be perceived from the results.

It is completely true that deletion of a chromosomal region in a proportion of cells is equal to the underexpression of deleted genes. However, in this study, we specifically focused on the lncRNA LINC00987, not other genes neighboring that. Even though under-expression of other genes might affect the overall survival of LUAD patients, we specifically investigated whether the expression level of LINC00987 is associated with the overall survival of LUAD patients or not. This is a common and approved strategy and statistical analysis.

Actually, this is a research note, not a comprehensive research paper, which could be an inspiring viewpoint for the conduction of further in-silico and in-vitro assays on the association of LINC00987 and LUAD.

Overall, thank you for your precious time and consideration.
We agree with you about the clarification of gene nomenclature. Actually, LINC00987 was previously known as LOC100499405. Please take a look at row 817 of the Table S5 of the paper by Xu et al. You may also get this point by checking the RefSeq transcript ID (NR_036466) of LINC00987 and LOC100499405. We will consider clarifying on this point in the next revision of the paper.

According to the results obtained from the TCGA Copy Number Portal, LINC00987 is located within a focal peak region of deletion (chr12:2782810-17821101) in LUAD. Basically, this means that the gene LINC00987 and several other genes are frequently deleted in LUAD patients. However, no distinctive association between LINC00987 deletion and LUAD could be perceived from the results.

It is completely true that deletion of a chromosomal region in a proportion of cells is equal to the underexpression of deleted genes. However, in this study, we specifically focused on the lncRNA LINC00987, not other genes neighboring that. Even though under-expression of other genes might affect the overall survival of LUAD patients, we specifically investigated whether the expression level of LINC00987 is associated with the overall survival of LUAD patients or not. This is a common and approved strategy and statistical analysis.

Actually, this is a research note, not a comprehensive research paper, which could be an inspiring viewpoint for the conduction of further in-silico and in-vitro assays on the association of LINC00987 and LUAD.

Overall, thank you for your precious time and consideration.
Competing Interests: No competing interests were disclosed. Close
Report a concern

Comments on this article Comments (0)

Version 1

VERSION 1 PUBLISHED 04 May 2018

Open Peer Review

Reviewer Status

Reviewer Reports

	Invited Reviewers
	1	2
Version 1 04 May 18	read	read

Antonio Marco, University of Essex, Colchester, UK
Wen Cai Zhang, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, USA

Comments on this article

All Comments(0)

Add a comment

Browse by related subjects

Back to all reports

Reviewer Report

9 Views

31 Aug 2018 | for Version 1

Wen Cai Zhang, Department of Pathology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA

9 Views Cite this report Responses(0)

Approved With Reservations

Could any known lung relevant lncRNAs (such as MALAT1) be applied and validated using the database (GEPIA)?
Could the author reproduce the data shown in Fig 1b and 1c using a different database to demonstrate differential expressions of LINC00987 in lung adenocarcinoma and normal tissues and survival curve?
Could the author validate the differential expression levels for LINC00987 in several lung adenocarcinoma and normal lung epithelial cell lines?
Furthermore, could plasmids for LINC00987 be applied to validate the tumor suppressive roles in lung adenocarcinoma cell lines?

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Tumor initiation/progression, cancer metabolism, non-coding RNAs

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

31 Views

07 Jun 2018 | for Version 1

Antonio Marco, School of Biological Sciences, University of Essex, Colchester, UK

31 Views Cite this report Responses(1)

Not Approved

The choice of LINC00987 as a potential gene involved in this cancer is based on a paper by Xu et al. After screening the paper and the supplementary annotation I haven't found any mention to it. It may be due to a change in nomenclature, but then it must be clearly stated.
The deletion of LINC00987 is associated to a deletion of half on an arm of chromosome 12. There are hundreds of genes in the region so any association to LINC00987 must be clearly differentiated.
Likewise, the expression levels can be associated to this deletion. Hundreds of other genes will be also underexpressed. This also affects the analysis of Figure 1C.

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Non-coding RNAs, Gene expression, Evolution, Genomics, Computational Biology

Respond to this report

Responses (1)

Author Response

08 Jun 2018

Abbas Salavaty, Division of Biotechnology, Department of Cell and Molecular Biology, Faculty of Chemistry, University of Kashan, Kashan, Iran

We agree with you about the clarification of gene nomenclature. Actually, LINC00987 was previously known as LOC100499405. Please take a look at row 817 of the Table S5 of the paper by Xu et al. You may also get this point by checking the RefSeq transcript ID (NR_036466) of LINC00987 and LOC100499405. We will consider clarifying on this point in the next revision of the paper.
According to the results obtained from the TCGA Copy Number Portal, LINC00987 is located within a focal peak region of deletion (chr12:2782810-17821101) in LUAD. Basically, this means that the gene LINC00987 and several other genes are frequently deleted in LUAD patients. However, no distinctive association between LINC00987 deletion and LUAD could be perceived from the results.
It is completely true that deletion of a chromosomal region in a proportion of cells is equal to the underexpression of deleted genes. However, in this study, we specifically focused on the lncRNA LINC00987, not other genes neighboring that. Even though under-expression of other genes might affect the overall survival of LUAD patients, we specifically investigated whether the expression level of LINC00987 is associated with the overall survival of LUAD patients or not. This is a common and approved strategy and statistical analysis.

Actually, this is a research note, not a comprehensive research paper, which could be an inspiring viewpoint for the conduction of further in-silico and in-vitro assays on the association of LINC00987 and LUAD.

Overall, thank you for your precious time and consideration.

View more View less

Competing Interests

No competing interests were disclosed.

Alongside their report, reviewers assign a status to the article:

Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions

Click here to access the data.

Downloaded data do not display as expected? Download the data

[1] 1. Torre LA, Siegel RL, Jemal A: Lung Cancer Statistics. Adv Exp Med Biol. 2016; 893: 1–19. PubMed Abstract | Publisher Full Text

[2] 2. Chen Z, Fillmore CM, Hammerman PS, et al.: Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014; 14(8): 535–46. PubMed Abstract | Publisher Full Text | Free Full Text

[3] 3. Torre LA, Bray F, Siegel RL, et al.: Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2): 87–108. PubMed Abstract | Publisher Full Text

[4] 4. Shen XH, Qi P, Du X: Long non-coding RNAs in cancer invasion and metastasis. Mod Pathol. 2015; 28(1): 4–13. PubMed Abstract | Publisher Full Text

[5] 5. Anastasiadou E, Jacob LS, Slack FJ: Non-coding RNA networks in cancer. Nat Rev Cancer. 2018; 18(1): 5–18. PubMed Abstract | Publisher Full Text

[6] 6. Bolha L, Ravnik-Glavač M, Glavač D: Long Noncoding RNAs as Biomarkers in Cancer. Dis Markers. 2017; 2017: 7243968. PubMed Abstract | Publisher Full Text | Free Full Text

[7] 7. Hajjari M, Salavaty A: HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol Med. 2015; 12(1): 1–9. PubMed Abstract | Publisher Full Text | Free Full Text

[8] 8. Xu G, Chen J, Pan Q, et al.: Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis. PLoS One. 2014; 9(8): e104044. PubMed Abstract | Publisher Full Text | Free Full Text

[9] 9. Gao J, Aksoy BA, Dogrusoz U, et al.: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6(269): pl1. PubMed Abstract | Publisher Full Text | Free Full Text

[10] 10. Cerami E, Gao J, Dogrusoz U, et al.: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5): 401–4. PubMed Abstract | Publisher Full Text | Free Full Text

[11] 11. Beroukhim R, Mermel CH, Porter D, et al.: The landscape of somatic copy-number alteration across human cancers. Nature. 2010; 463(7283): 899–905. PubMed Abstract | Publisher Full Text | Free Full Text

[12] 12. Tang Z, Li C, Kang B, et al.: GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1): W98–W102. PubMed Abstract | Publisher Full Text | Free Full Text

[13] 13. Balmain A, Gray J, Ponder B: The genetics and genomics of cancer. Nat Genet. 2003; 33 Suppl: 238–44. PubMed Abstract | Publisher Full Text

[14] 14. Dong JT: Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev. 2001; 20(3–4): 173–93. PubMed Abstract | Publisher Full Text

[15] 15. Chen J, Fu L, Zhang LY, et al.: Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma. Chin J Cancer. 2012; 31(5): 215–22. PubMed Abstract | Publisher Full Text | Free Full Text

[16] 16. Salavaty A, Rezvani Z, Najafi A: Dataset 1 in: Long non-coding RNA LINC00987 may function as a tumor suppressor in lung adenocarcinoma. F1000Research. 2018. Data Source

Long non-coding RNA LINC00987 may function as a tumor suppressor in lung adenocarcinoma

Abstract

Keywords

Introduction

Methods

Genomic analysis

Transcriptomic analysis

Results

LINC00987 has genomic alterations in LUAD

Figure 1. Genomic and transcriptomic alterations of LINC00987 long non-coding RNA (lncRNA) in lung adenocarcinoma (LUAD).

LINC00987 is downregulated in LUAD

Discussion

Data availability

Competing interests

Grant information

Acknowledgements

References

Comments on this article Comments (0)

Open Peer Review

Comments on this article Comments (0)

Open Peer Review

Reviewer Status

Reviewer Reports

Comments on this article

Browse by related subjects

The problem

How to fix it

Competing Interests Policy

Stay Updated